Sound waves could supercharge chemo for tough pancreatic cancer
NCT ID NCT04821284
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new method called sonoporation, which uses ultrasound and tiny gas bubbles to help chemotherapy drugs get into cancer cells more effectively. The trial includes 120 adults with advanced or hard-to-remove pancreatic cancer who are already receiving standard chemotherapy. The goal is to see if adding sonoporation can slow cancer growth and help patients tolerate more treatment cycles.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED PANCREATIC DUCTAL ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Haukeland University Hospital
Bergen, 5021, Norway
-
Sidney Kimmel Cancer Center at Thomas Jefferson University
Philadelphia, Pennsylvania, 19107, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can an immunotherapy cocktail slow pancreatic cancer? a new trial aims to find out.
- Could a Decades-Old parasite drug help fight pancreatic cancer?
- Smart drug delivers chemo directly to pancreatic cancer cells
- New drug combo aims to shrink Hard-to-Treat pancreatic and ovarian tumors
- Triple threat against pancreatic cancer: radiation, immunotherapy, and chemotherapy combined
- Engineered T-Cells take aim at Hard-to-Treat pancreatic cancer